Home › Stocks › 4530
Tokyo-listed stock · 4530
Hisamitsu Pharmaceutical (4530): large-holder filings
In the last 12 months, large holders reported 6 changes to stakes of 5% or more.
Stakes raised / cut 5 / 112 months
Large holders filing 312 months
6 disclosed buys and sales on record since 14 January 2026. A large holder files with EDINET when a stake of 5% or more moves by a point or more; a change has a value once it can be priced.
Latest disclosures
Disclosed Filed by Type Amount Traded
12 May 2026 CREDIT INDUSTRIEL ET COMMERCIAL5% holder (Japan)
Buy
Not valued
30 Apr 2026
30 Apr 2026 CREDIT INDUSTRIEL ET COMMERCIAL5% holder (Japan)
Buy
Not valued
22 Apr 2026
6 Apr 2026 CREDIT INDUSTRIEL ET COMMERCIAL5% holder (Japan)
Buy
Not valued
30 Mar 2026
2 Mar 2026 株式会社三菱UFJフィナンシャル・グループ5% holder (Japan)
Sale
Not valued
23 Feb 2026
27 Feb 2026 TAIYO KOSAN CO.,INC.5% holder (Japan)
Buy
¥253B ($1.6B)
19 Feb 2026
14 Jan 2026 TAIYO KOSAN CO.,INC.5% holder (Japan)
Buy
Not valued
6 Jan 2026
Columns are written from public disclosures: House and Senate periodic transaction reports, SEC Form 4, Japan’s EDINET large-holding reports and Taiwan’s insider registers and market data (TWSE, TPEx, MOPS and the central bank, with history from FinMind). Stock pages add SEC 13F fund holdings and company financials, analysts’ figures from Financial Modeling Prep and Finnhub, and lobbying and federal contract records from the Senate and USAspending.gov. Amounts are disclosed as ranges, so the figures are estimates. Nothing here is investment advice.
Home · Features · Columns · Members of Congress · Stocks · Sitemap · RSS feed of the columns · Privacy and security
Follow us on X Bluesky LinkedIn